To test this, we knockdown GRP78 by siRNA in a panel of 7 human non-small-cell lung carcinoma cell lines (NSCLCs) bearing different EGFR genotypes, including the commonly mutated and amplified EGFR alleles (SI Appendix, Table S1). This evidence concerns the gene HSPA5 and non-small cell lung carcinoma.